Valero Energy Corporation (VLO) saw its value decrease by -1.71% as the stock dropped $-1.16 to finish the day at a closing price of $66.6. The stock was lighter in trading and has fluctuated between $46.88-$71.4 per share for the past year. The shares, which traded within a range of $66.39 to $67.61 during the day, are up by 7.57% in the past three months and up by 23.13% over the past six months. It is currently trading 0.67% above its 20 day moving average and 0.13% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $73.09 a share over the next twelve months. The current relative strength index (RSI) reading is 51.23.The technical indicator lead us to believe there will be no major movement any time soon, hold.
Valero Energy Corporation operates as an independent petroleum refining and marketing company in the United States, Canada, the Caribbean, the United Kingdom, and Ireland. It operates through two segments, Refining and Ethanol. The Refining segment is involved in refining, wholesale marketing, and bulk sales and trading activities. This segment produces conventional and premium gasolines, gasoline meeting the specifications of the California Air Resources Board (CARB), reformulated gasoline blendstock for oxygenate blending, diesel fuels, low-sulfur and ultra-low-sulfur diesel fuels, CARB diesel fuel, distillates, jet fuels, asphalts, petrochemicals, lubricants, and other refined products. As of February 19, 2016, it owned 15 petroleum refineries with a combined throughput capacity of approximately 3.0 million barrels per day. This segment also markets its refined products through bulk and rack marketing network; and through approximately 7,500 outlets under the Valero, Diamond Shamrock, Shamrock, Ultramar, Beacon, and Texaco brand names. The Ethanol segment produces and sells ethanol and distillers grains primarily to refiners and gasoline blenders, as well as to animal feed customers. This segment operates 11 ethanol plants with a combined ethanol production capacity of approximately 1.4 billion gallons per year. The company also operates a 50-megawatt wind farm; convenience stores; filling stations, as well as truckstop, cardlock, and home heating oil facilities; and credit card business. The company was formerly known as Valero Refining and Marketing Company and changed its name to Valero Energy Corporation in August 1997. Valero Energy Corporation was founded in 1955 and is headquartered in San Antonio, Texas.
The Dow Chemical Company (DOW) shares were up in last trading by 0.51% to $61.41. It experienced lighter than average volume on day. The stock increased in value by almost 1.91% over the past week and grew 6.41% in the past month. It is currently trading 4.83% above its 50 day moving average and 14.62% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -0.71% decrease in value from its one year high of $61.85. The RSI indicator value of 62.41, lead us to believe that it is a hold for now.
The Dow Chemical Company manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide. It operates through five segments: Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals, and Performance Plastics segments. The Agricultural Sciences segment provides crop protection and seed/plant biotechnology products and technologies, urban pest management solutions, and healthy oils. The Consumer Solutions segment offers semiconductors and organic light-emitting diodes, adhesives, and foams for use in the transportation industry; cellulosics and other polymers for pharmaceutical formulations and food solutions; and silicone solutions used in consumer goods and automotive applications. The Infrastructure Solutions segment provides architectural and industrial coatings, construction material ingredients, building insulation products, adhesives, and microbial protection products for the oil and gas industry, telecommunications, and light and water technologies. The Performance Materials & Chemicals segment offers chlorine and caustic soda; industrial solutions; and propylene oxides, propylene glycols, polyether polyols, and aromatic isocyanates. The Performance Plastics segment provides elastomers, polyolefin plastomers, and ethylene propylene diene monomer elastomers; wire and cable insulation, semiconductive, and jacketing compound solutions, as well as bio-based plasticizers; acrylics, polyethylene, and polyolefin plastomers; and ethylene, propylene, benzene, butadiene, octene, aromatics co-products, and crude c4. The company was founded in 1897 and is based in Midland, Michigan.
Mylan N.V. (MYL) traded within a range of $41.56 to $42.65 after opening the day at $42.6. The company has seen its stock increase in value by 10.09% so far this year. The stock was down close to -1.04% on light volume in last trading session and closed at $42 per share. After the recent fall, the stock is currently holding -16.67% below its 52 week high of $50.4 and 25% above its 12-month low of $33.6. The shares are up by over 8.64% in the last three months, and the RSI indicator value of 71.33 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of APIs with non-infringing processes for internal use and to partner with manufacturers; and manufacture and sale of injectable products in antineoplastics, anti-infectives, anesthesia/pain management, and cardiovascular therapeutic areas. In addition, the company produces finished dosage form and oral solid dose products; and offers antiretroviral therapies to third parties. Further, it manufactures and sells branded specialty injectable and nebulized products comprising EpiPen Auto-Injector to treat severe allergic reactions; Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients; and ULTIVA, an analgesic agent used during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. It sells generic pharmaceutical products to proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies; and specialty pharmaceuticals to pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. Mylan N.V. has a collaboration agreement with Momenta Pharmaceuticals, Inc. to develop, manufacture, and commercialize Momenta Pharmaceuticals, Inc.’s biosimilar candidates. The company was formerly known as New Moon B.V. Mylan N.V. was founded in 1961 and is based in Hertfordshire, the United Kingdom.